Related Experiment Videos
Effects of AC-1370, a new semisynthetic cephalosporin, on phagocyte functions
Abstract:
The effects of a new semisynthetic cephalosporin, AC-1370, on phagocyte functions were compared with those of cefoperazone. AC-1370 augmented phagocytosis by mouse macrophages in vitro and in vivo, by mouse neutrophils in vivo, and by human neutrophils in vitro. Cefoperazone suppressed phagocytosis by mouse macrophages and neutrophils. Random migration and chemotaxis of mouse and human neutrophils were increased by the addition of AC-1370. Nitroblue tetrazolium reduction by human neutrophils was enhanced by the addition of AC-1370. Intracellular killing of bacteria by macrophages was also enhanced by AC-1370. Further, bactericidal effects of AC-1370 against Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae were augmented when they were each cultured with mouse or human leukocytes. These results suggest that AC-1370 is an unique beta-lactam antibiotic which has a potentiating effect on phagocyte functions as well as a bactericidal effect.
Insights
The novel cephalosporin AC-1370 enhances phagocyte functions and bacterial killing, unlike cefoperazone which suppresses these activities. This suggests AC-1370 is a unique beta-lactam antibiotic with dual therapeutic potential.
Area of Science:
- Immunology
- Microbiology
- Pharmacology
Background:
- Phagocyte cells are crucial for innate immunity.
- Beta-lactam antibiotics are widely used to combat bacterial infections.
Purpose of the Study:
- To compare the effects of a new semisynthetic cephalosporin, AC-1370, with cefoperazone on phagocyte functions.
- To investigate the impact of AC-1370 on phagocytosis, neutrophil migration, and intracellular bacterial killing.
Main Methods:
- In vitro and in vivo experiments using mouse macrophages and neutrophils, and human neutrophils.
- Assays included phagocytosis, random migration, chemotaxis, Nitroblue tetrazolium reduction, and intracellular killing.
- Bactericidal effects were assessed by culturing bacteria with leukocytes.
Main Results:
- AC-1370 augmented phagocytosis in mouse macrophages and neutrophils, and human neutrophils.
- Cefoperazone suppressed phagocytosis in mouse macrophages and neutrophils.
- AC-1370 enhanced neutrophil migration, Nitroblue tetrazolium reduction, and intracellular bacterial killing by macrophages.
- AC-1370 boosted bactericidal effects against Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae in the presence of leukocytes.
Conclusions:
- AC-1370 demonstrates a unique ability to potentiate phagocyte functions.
- AC-1370 exhibits both direct bactericidal effects and immunomodulatory properties.
- AC-1370 represents a promising beta-lactam antibiotic with enhanced immune-supportive capabilities.